| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5821805 | Antiviral Research | 2016 | 33 Pages |
Abstract
This new method with low level detection of baseline RAVs could be useful in predicting the most cost-efficient combination of DAA treatment, and reduce the treatment duration for an HCV infected individual.
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
Assar Bergfors, Daniël Leenheer, Anders Bergqvist, Adam Ameur, Johan Lennerstrand,